羊膜市場：製品、用途、エンドユーザー別- 2023-2030年の世界予測

羊膜の市場規模は、2022年に9億3,183万米ドルと推定され、2023年には10億2,673万米ドルに達し、 CAGR 9.37%で2030年までに19億860万米ドルに達すると予想されています。

世界の羊膜市場

羊膜市場には、さまざまな医療アプリケーション向けの羊膜の製造、配布、販売が含まれます。 羊膜は胎盤の最内層に由来し、細胞と細胞外マトリックスの独自の組み合わせを含み、さまざまな治療実践、特に眼科、創傷ケア、外科手術で使用される再生特性を持っています。 羊膜は、抗炎症、抗線維化、抗菌特性と、幹細胞の増殖をサポートする能力により、さまざまな医療用途に利用されています。それにもかかわらず、羊膜市場の成長は、倫理的制約、規制、コスト制約など、いくつかの制限や困難な要因に直面しています。凍結保存や脱水製品などの保存技術の進歩により、これらの膜の保管と輸送が容易になり、その入手可能性と保存期間が延長されました。現在進行中の調査により、羊膜の新しい治療用途が発見され、さらなる市場が開拓されています。 羊膜ベースの製品の利点についてヘルスケア従事者や患者の間で意識が高まっていることも、市場拡大の機会を生み出しています。

地域の洞察

南北アメリカの羊膜市場は、洗練されたヘルスケアインフラの強力な存在、医療従事者と患者の両方の間での意識の高まり、有利な償還政策によって大幅な成長を遂げています。米国は、確立されたヘルスケア制度と再生医療分野の主要企業の存在により、主要市場として際立っています。 欧州・中東・アフリカ地域では、眼科や創傷治療における採用の増加により、羊膜の需要が高まっています。欧州市場は、製品の品質と安全性を保証する厳しいEU規制に支えられ、特に堅調です。慢性疾患の増加と人口の高齢化が、この需要の高まりに寄与しています。中東はヘルスケアインフラへの投資増加により成長の可能性を示していますが、欧州に比べると市場への浸透はまだ初期段階にあります。アフリカでは、ヘルスケア施設が限られている、認知度が低いなどの課題があり、市場は比較的発展途上ですが、ヘルスケア制度が徐々に改善されており、今後の成長の可能性を秘めています。 アジア太平洋地域は、ヘルスケアインフラの急速な進歩、再生医療への投資の増加、患者人口の拡大により、羊膜にとって最も急速に成長する市場になると予想されています。中国、日本、インドなどの国々がこの成長軌道をリードしています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは、羊膜市場を評価する上で極めて重要です。ビジネス戦略と製品満足度に関連する主要な指標を調査し、ベンダーの包括的な評価を提供します。この詳細な分析により、ユーザーは十分な情報に基づいて要件に合わせた意思決定を行うことができます。評価に基づいて、ベンダーはさまざまな成功レベルを表す4つの異なる象限（Forefront（F）、Pathfinder（P）、Niche（N）、またはVital（V））に分類されます。

市場シェア分析

マーケットシェア分析は、羊膜市場のベンダーの現状を洞察力に富んだ詳細な調査で提供する包括的なツールです。全体的な収益、顧客ベース、その他の主要な指標の観点からベンダーの貢献を注意深く比較および分析することで、企業が自社のパフォーマンスと市場シェアを争う際に直面する課題をより深く理解できるようになります。さらに、この分析は、調査対象の基準年期間にわたって観察された蓄積、断片化の優位性、融合特性などの要因を含む、セクターの競争特性に関する貴重な洞察を提供します。この詳細レベルの拡張により、ベンダーはより多くの情報に基づいた意思決定を行い、市場での競争力を獲得するための効果的な戦略を考案できるようになります。

このレポートは、次の側面に関する貴重な洞察を提供します。

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を示します。

2-市場の発掘：収益性の高い新興市場を深く掘り下げ、成熟した市場セグメント全体への浸透を分析します。

3-市場の多様性：新製品の発売、未開発の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制当局の承認、特許情勢、製造能力の徹底的な評価を実施します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察を提供します。

このレポートでは、次のような重要な質問が取り上げられています。

1-羊膜市場の市場規模と予測は？

2-羊膜市場の予測期間中に投資を検討すべき製品、セグメント、アプリケーション、および分野はどれですか?

3-羊膜市場における技術動向と規制の枠組みは何ですか?

4-羊膜市場における主要ベンダーの市場シェアはどれくらいですか?

5-羊膜市場への参入に適したモードと戦略的動きはどれですか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 羊膜移植の需要
    • 世界中で高齢者人口が増加
    • 事故や外傷事件の発生率の増加
  • 抑制要因
    • ヘルスケア分野における熟練した専門家の不足
  • 機会
    • 再生医療と幹細胞生物学の羊膜における研究開発活動の増加
    • 羊膜の特典と出産用組織の寄付に対する意識の高まり
  • 課題
    • 十分な保管温度レベルを維持する
• 市場セグメンテーション分析
  • 製品：凍結保存羊膜生細胞療法の使用の増加
  • 用途：複雑な眼表面疾患を治療する眼科における羊膜の採用
  • エンドユーザー：外科手術のために病院全体で重要に使用される製品
• 市場動向分析
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 羊膜市場：製品別

• 冷凍保存された羊膜
• 凍結乾燥羊膜

第7章 羊膜市場：用途別

• 眼科
• 手術の傷

第8章 羊膜市場：エンドユーザー別

• 外来手術センター
• 病院
• 研究センター研究室
• 専門クリニック

第9章 南北アメリカの羊膜市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の羊膜市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの羊膜市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ主要企業別の分析
  • 合併・買収
  • 契約、コラボレーション、パートナーシップ

第13章 競争力のあるポートフォリオ

• 主要な企業プロファイル
  • Applied Biologics, LLC
  • BioStem Technologies, Inc.
  • BioTissue Holdings, Inc.
  • Celularity Inc.
  • FzioMed Inc.
  • Genesis Biologics Inc.
  • Integra LifeSciences Holdings Corporation
  • Katena Products, Inc.
  • Laboratoire CCD
  • Lucina BioSciences, LLC
  • Merakris Therapeutics
  • MiMedx Group, Inc.
  • Next Biosciences（Pty）Limited
  • NuVision Biotherapies Ltd
  • Organogenesis Holdings Inc.
  • PuraGraft
  • Seed Biotech, Inc.
  • Skye Biologics Holdings, LLC
  • Smith & Nephew PLC
  • Stryker Corporation
  • Surgenex, LLC
  • Surgilogix
  • The Electrospinning Company
  • Thea Pharma Inc.
  • Ventris Medical, LLC
  • VIVEX Biologics, Inc.
• 主要な製品ポートフォリオ

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. AMNIOTIC MEMBRANE MARKET RESEARCH PROCESS
• FIGURE 2. AMNIOTIC MEMBRANE MARKET SIZE, 2022 VS 2030
• FIGURE 3. AMNIOTIC MEMBRANE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 5. AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 6. AMNIOTIC MEMBRANE MARKET DYNAMICS
• FIGURE 7. AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 8. AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 10. AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 12. AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 14. AMERICAS AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY STATE, 2022 VS 2030 (%)
• FIGURE 16. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 21. AMNIOTIC MEMBRANE MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 22. AMNIOTIC MEMBRANE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. AMNIOTIC MEMBRANE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. AMNIOTIC MEMBRANE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 6. AMNIOTIC MEMBRANE MARKET SIZE, BY CRYOPRESERVED AMNIOTIC MEMBRANE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. AMNIOTIC MEMBRANE MARKET SIZE, BY LYOPHILIZATION AMNIOTIC MEMBRANE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 9. AMNIOTIC MEMBRANE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. AMNIOTIC MEMBRANE MARKET SIZE, BY SURGICAL WOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 12. AMNIOTIC MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMNIOTIC MEMBRANE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMNIOTIC MEMBRANE MARKET SIZE, BY RESEARCH CENTERS LABORATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMNIOTIC MEMBRANE MARKET SIZE, BY SPECIALIZED CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. CANADA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. CANADA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. CANADA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. CHINA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. CHINA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. CHINA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. INDIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. INDIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. INDIA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. ITALY AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. ITALY AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ITALY AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. POLAND AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. POLAND AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. POLAND AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. QATAR AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. QATAR AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. QATAR AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. AMNIOTIC MEMBRANE MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 144. AMNIOTIC MEMBRANE MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 145. AMNIOTIC MEMBRANE MARKET LICENSE & PRICING

[193 Pages Report] The Amniotic Membrane Market size was estimated at USD 931.83 million in 2022 and expected to reach USD 1,026.73 million in 2023, at a CAGR 9.37% to reach USD 1,908.60 million by 2030.

Global Amniotic Membrane Market

The amniotic membrane market encompasses producing, distributing, and selling amniotic membranes for various medical applications. Amniotic membranes, derived from the innermost layer of the placenta and contain a unique combination of cells and extracellular matrix, have regenerative properties used in various therapeutic practices, especially in ophthalmology, wound care, and surgical procedures. Amniotic membranes are utilized in various medical applications due to their anti-inflammatory, anti-fibrotic, and anti-microbial properties and their ability to support stem cell proliferation. Nonetheless, the growth of the amniotic membrane market faces several limitations and challenging factors, such as ethical constraints, regulation, and cost constraints. Advances in preservation technologies, such as cryopreservation and dehydrated products, are making storing and transporting these membranes easier, thus expanding their availability and shelf-life. Ongoing research is discovering new therapeutic applications for the amniotic membrane, opening up further markets. Increased awareness among healthcare professionals and patients about the benefits of amniotic membrane-based products is also creating opportunities for market expansion.

Regional Insights

The amniotic membrane market in the Americas is experiencing substantial growth, driven by a strong presence of sophisticated healthcare infrastructure, heightened awareness amongst both practitioners and patients, and favorable reimbursement policies. The United States stands out as the primary market due to its well-established healthcare system and the presence of key players in the regenerative medicine sector. In the EMEA region, demand for amniotic membranes is growing, driven by increased adoption in ophthalmology and wound care. The European market is particularly robust, supported by stringent EU regulations that ensure product quality and safety. The rise in chronic diseases and an aging population contribute to this heightened demand. The Middle East exhibits growth potential with increased investments in healthcare infrastructure, though market penetration is still in its nascent stages compared to Europe. In Africa, the market is relatively underdeveloped, faced with challenges such as limited healthcare facilities and lower awareness levels, but it holds potential for future growth due to a gradual improvement in healthcare systems. The APAC region is anticipated to be the fastest-growing market for amniotic membranes, thanks to rapidly advancing healthcare infrastructure, increasing investments in regenerative medicine, and an expansive patient population. Countries like China, Japan, and India are leading this growth trajectory.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Amniotic Membrane Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Amniotic Membrane Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Amniotic Membrane Market, highlighting leading vendors and their innovative profiles. These include Applied Biologics, LLC, BioStem Technologies, Inc., BioTissue Holdings, Inc., Celularity Inc., FzioMed Inc., Genesis Biologics Inc., Integra LifeSciences Holdings Corporation, Katena Products, Inc., Laboratoire CCD, Lucina BioSciences, LLC, Merakris Therapeutics, MiMedx Group, Inc., Next Biosciences (Pty) Limited, NuVision Biotherapies Ltd, Organogenesis Holdings Inc., PuraGraft, Seed Biotech, Inc., Skye Biologics Holdings, LLC, Smith & Nephew PLC, Stryker Corporation, Surgenex, LLC, Surgilogix, The Electrospinning Company, Thea Pharma Inc., Ventris Medical, LLC, and VIVEX Biologics, Inc..

Market Segmentation & Coverage

This research report categorizes the Amniotic Membrane Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Cryopreserved Amniotic Membrane
  • Lyophilization Amniotic Membrane
• Application
  • Ophthalmology
  • Surgical Wound
• End User
  • Ambulatory Surgical Center
  • Hospital
  • Research Centers Laboratory
  • Specialized Clinic
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Amniotic Membrane Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Amniotic Membrane Market?

3. What are the technology trends and regulatory frameworks in the Amniotic Membrane Market?

4. What is the market share of the leading vendors in the Amniotic Membrane Market?

5. Which modes and strategic moves are suitable for entering the Amniotic Membrane Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Amniotic Membrane Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Demand for amniotic membrane transplantations
    • 5.1.1.2. Rising the geriatric population around the world
    • 5.1.1.3. Growing incidence of accident and trauma cases
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of skilled professionals in healthcare sector
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing R&D activities in the amniotic membrane for regenerative medicine and stem cell biology
    • 5.1.3.2. Growing awareness of amniotic membrane benefits and birth tissue donations
  • 5.1.4. Challenges
    • 5.1.4.1. Maintaining sufficient storage temperature level
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increase in use of cryopreserved amniotic membranes live cell therapy
  • 5.2.2. Application: Employment of amniotic membrane in ophthalmology treating complex ocular surface diseases
  • 5.2.3. End User: Significant use products across Hospitals for surgical procedures
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of COVID-19
• 5.5. Cumulative Impact of Russia-Ukraine Conflict
• 5.6. Cumulative Impact of High Inflation
• 5.7. Porter's Five Forces Analysis
  • 5.7.1. Threat of New Entrants
  • 5.7.2. Threat of Substitutes
  • 5.7.3. Bargaining Power of Customers
  • 5.7.4. Bargaining Power of Suppliers
  • 5.7.5. Industry Rivalry
• 5.8. Value Chain & Critical Path Analysis
• 5.9. Regulatory Framework
• 5.10. Client Customization

6. Amniotic Membrane Market, by Product

• 6.1. Introduction
• 6.2. Cryopreserved Amniotic Membrane
• 6.3. Lyophilization Amniotic Membrane

7. Amniotic Membrane Market, by Application

• 7.1. Introduction
• 7.2. Ophthalmology
• 7.3. Surgical Wound

8. Amniotic Membrane Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Center
• 8.3. Hospital
• 8.4. Research Centers Laboratory
• 8.5. Specialized Clinic

9. Americas Amniotic Membrane Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Amniotic Membrane Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Amniotic Membrane Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player
  • 12.3.1. Merger & Acquisition
    • 12.3.1.1. Coloplast announces agreement to acquire Kerecis and raises long-term growth expectations
  • 12.3.2. Agreement, Collaboration, & Partnership
    • 12.3.2.1. NovaBay to commercialize Amniotic Tissue Allograft as Avenova Allograft

13. Competitive Portfolio

• 13.1. Key Company Profiles
  • 13.1.1. Applied Biologics, LLC
  • 13.1.2. BioStem Technologies, Inc.
  • 13.1.3. BioTissue Holdings, Inc.
  • 13.1.4. Celularity Inc.
  • 13.1.5. FzioMed Inc.
  • 13.1.6. Genesis Biologics Inc.
  • 13.1.7. Integra LifeSciences Holdings Corporation
  • 13.1.8. Katena Products, Inc.
  • 13.1.9. Laboratoire CCD
  • 13.1.10. Lucina BioSciences, LLC
  • 13.1.11. Merakris Therapeutics
  • 13.1.12. MiMedx Group, Inc.
  • 13.1.13. Next Biosciences (Pty) Limited
  • 13.1.14. NuVision Biotherapies Ltd
  • 13.1.15. Organogenesis Holdings Inc.
  • 13.1.16. PuraGraft
  • 13.1.17. Seed Biotech, Inc.
  • 13.1.18. Skye Biologics Holdings, LLC
  • 13.1.19. Smith & Nephew PLC
  • 13.1.20. Stryker Corporation
  • 13.1.21. Surgenex, LLC
  • 13.1.22. Surgilogix
  • 13.1.23. The Electrospinning Company
  • 13.1.24. Thea Pharma Inc.
  • 13.1.25. Ventris Medical, LLC
  • 13.1.26. VIVEX Biologics, Inc.
• 13.2. Key Product Portfolio

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing